Stockman Wealth Management, Inc. Eli Lilly & CO Transaction History

Stockman Wealth Management, Inc.

$554 Million
Q2 2024

A detailed history of Stockman Wealth Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stockman Wealth Management, Inc. holds 2,368 shares of LLY stock, worth $2.1 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares

2,368

Previous 2,330 1.63%

Holding current value

$2.1 Million

Previous $1.81 Million 18.27%

% of portfolio

0.39%

Previous 0.33%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $27,545 - $34,543	38 Added 1.63%	2,368 $2.14 Million
Q1 2024 Apr 17, 2024	BUY	$592.2 - $792.28 $45,007 - $60,213	76 Added 3.37%	2,330 $1.81 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $27,835 - $32,813	-53 Reduced 2.3%	2,254 $1.31 Million
Q3 2023 Oct 31, 2023	BUY	$434.7 - $599.3 $21,735 - $29,964	50 Added 2.22%	2,307 $1.24 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $28,409 - $37,987	-81 Reduced 3.46%	2,257 $1.06 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $18,327 - $21,524	-59 Reduced 2.46%	2,338 $802,000
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $67,525 - $78,680	210 Added 9.6%	2,397 $876,000
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $4,447 - $5,068	-15 Reduced 0.68%	2,187 $707,000
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $32,332 - $37,963	116 Added 5.56%	2,202 $714,000
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $139,171 - $172,954	593 Added 39.72%	2,086 $597,000
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $10,118 - $12,556	-45 Reduced 2.93%	1,493 $412,000
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $13,960 - $17,180	63 Added 4.27%	1,538 $355,000
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $25,277 - $32,695	140 Added 10.49%	1,475 $339,000
Q1 2021 May 05, 2021	SELL	$164.32 - $212.72 $51,760 - $67,006	-315 Reduced 19.09%	1,335 $249,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $20,221 - $26,757	155 Added 10.37%	1,650 $279,000
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $18,277 - $21,141	-125 Reduced 7.72%	1,495 $221,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $12,550 - $15,104	-92 Reduced 5.37%	1,620 $266,000
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $3,095 - $3,831	26 Added 1.54%	1,712 $237,000
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $180,267 - $223,276	1,686 New	1,686 $222,000
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $3.32 Million - $4.15 Million	-38,697 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $143,527 - $164,724	1,896 Added 5.15%	38,697 $3.3 Million
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $258,250 - $304,848	3,480 Added 10.44%	36,801 $2.85 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $25,073 - $26,894	306 Added 0.93%	33,321 $2.81 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $2.24 Million - $2.48 Million	29,006 Added 723.52%	33,015 $2.82 Million
Q2 2017 Aug 09, 2017	BUY	N/A	4,009	4,009 $330,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stockman Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stockman Wealth Management, Inc. with notifications on news.

Account

Stockman Wealth Management, Inc. Eli Lilly & CO Transaction History